+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Bioengineered Protein Drugs Market Report 2026 - Product Thumbnail Image

Bioengineered Protein Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Hyperparathyroidism - Pipeline Insight, 2026 - Product Thumbnail Image

Hyperparathyroidism - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
Biosimilars Market Report 2026 - Product Thumbnail Image

Biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biosimilar Hormones Market Report 2026 - Product Thumbnail Image

Biosimilar Hormones Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biosimilar Therapeutic Peptides Market Report 2026 - Product Thumbnail Image

Biosimilar Therapeutic Peptides Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Oncology Biosimilars Market Report 2026 - Product Thumbnail Image

Oncology Biosimilars Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Biosimilar Interleukins Market Report 2026 - Product Thumbnail Image

Biosimilar Interleukins Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Lung Cancer Drugs Market Report 2026 - Product Thumbnail Image

Lung Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Biologic & Biosimilar RA Drugs Market Report 2026 - Product Thumbnail Image

Biologic & Biosimilar RA Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Acute Myeloid Leukemia (AML) - Pipeline Insight, 2026 - Product Thumbnail Image

Acute Myeloid Leukemia (AML) - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 450 Pages
  • Global
From
From
From
From
Loading Indicator